BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1089 related articles for article (PubMed ID: 28134994)

  • 1. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.
    Geddes ER; Stout AB; Friedman PM
    Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study.
    Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S
    Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractional 532-nm KTP diode laser and 595-nm pulsed dye laser in treatment of facial telangiectatic erythema.
    Nam CH; Kim MH; Hong SP; Park BC
    J Cosmet Dermatol; 2019 Jun; 18(3):783-787. PubMed ID: 29974643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose 1064-nm Q-switched Nd:YAG laser for the treatment of melasma.
    Choi M; Choi JW; Lee SY; Choi SY; Park HJ; Park KC; Youn SW; Huh CH
    J Dermatolog Treat; 2010 Jul; 21(4):224-8. PubMed ID: 20509814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety Evaluation of Picosecond Alexandrite Laser with a Diffractive Lens Array for Treatment of Melasma in Asian Patients by VISIA Imaging System.
    Chen YT; Lin ET; Chang CC; Lin BS; Chiang HM; Huang YH; Lin HY; Wang KY; Chang TM
    Photobiomodul Photomed Laser Surg; 2019 Sep; 37(9):559-566. PubMed ID: 31411549
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the effectiveness of pulsed dye laser vs pulsed dye laser combined with ultrapulse fractional CO
    Ouyang HW; Li GF; Lei Y; Gold MH; Tan J
    J Cosmet Dermatol; 2018 Feb; 17(1):54-60. PubMed ID: 29392869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of purpuragenic 595 nm pulsed dye laser versus sequential emission of 595 nm pulsed dye laser and 1,064 nm Nd:YAG laser: a double-blind randomized controlled study.
    Campos MA; Sousa AC; Varela P; Baptista A; Menezes N
    Acta Dermatovenerol Alp Pannonica Adriat; 2019 Mar; 28(1):1-5. PubMed ID: 30901061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a fractional picosecond 1,064 nm laser for the treatment of dermal and mixed type melasma.
    Chalermchai T; Rummaneethorn P
    J Cosmet Laser Ther; 2018 Jun; 20(3):134-139. PubMed ID: 29020467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective?
    Gokalp H; Akkaya AD; Oram Y
    J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the safety and efficacy of the dual wavelength picosecond laser for the treatment of benign pigmented lesions in Asians.
    Kung KY; Shek SY; Yeung CK; Chan HH
    Lasers Surg Med; 2019 Jan; 51(1):14-22. PubMed ID: 30357871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients.
    Yue B; Yang Q; Xu J; Lu Z
    Lasers Med Sci; 2016 Nov; 31(8):1657-1663. PubMed ID: 27450275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of melasma with a low-fluence 1064 nm Q-switched Nd:YAG laser: Laser toning in Caucasian women.
    Micek I; Pawlaczyk M; Kroma A; Seraszek-Jaros A; Urbańska M; Gornowicz-Porowska J
    Lasers Surg Med; 2022 Mar; 54(3):366-373. PubMed ID: 34473361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
    Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
    Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the efficacy of a fractionated 1927 nm laser for diffuse dyspigmentation and actinic changes.
    Vingan NR; Panton JA; Barillas J; Lazzarini A; Hoopman J; Kenkel JM; Culver A
    Lasers Surg Med; 2023 Apr; 55(4):344-358. PubMed ID: 36950878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a Low Energy, Low Density, Non-Ablative Fractional 1927 nm Wavelength Laser for Facial Skin Resurfacing.
    Brauer JA; Alabdulrazzaq H; Bae YS; Geronemus RG
    J Drugs Dermatol; 2015 Nov; 14(11):1262-7. PubMed ID: 26580875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of 1927 nm fractional Thulium fiber laser for the treatment of melasma: a retrospective study of 100 patients.
    Kurmuş G; Tatlıparmak A; Aksoy B; Koç E; Aşiran Serdar Z; Ergin C
    J Cosmet Laser Ther; 2019; 21(7-8):408-411. PubMed ID: 31690148
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of efficacy between long-pulsed Nd:YAG laser and pulsed dye laser to treat rosacea-associated nasal telangiectasia.
    Kwon WJ; Park BW; Cho EB; Park EJ; Kim KH; Kim KJ
    J Cosmet Laser Ther; 2018 Oct; 20(5):260-264. PubMed ID: 29388843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of port wine stains using Pulsed Dye Laser, Erbium YAG Laser, and topical rapamycin (sirolimus)-A randomized controlled trial.
    Greveling K; Prens EP; van Doorn MB
    Lasers Surg Med; 2017 Jan; 49(1):104-109. PubMed ID: 27320685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractional 1064 nm Picosecond Laser in Treatment of Melasma and Skin Rejuvenation in Asians, A Prospective Study.
    Wong CSM; Chan MWM; Shek SYN; Yeung CK; Chan HHL
    Lasers Surg Med; 2021 Oct; 53(8):1032-1042. PubMed ID: 33544930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonablative 1927 nm fractional resurfacing for the treatment of facial photopigmentation.
    Brauer JA; McDaniel DH; Bloom BS; Reddy KK; Bernstein LJ; Geronemus RG
    J Drugs Dermatol; 2014 Nov; 13(11):1317-22. PubMed ID: 25607696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.